Cargando…
Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer
SIMPLE SUMMARY: In clinically localized prostate cancer, risk stratification (low-, intermediate- and high-risk) is crucial for the management of such a heterogenic disease, and it is based only on clinicopathologic features (i.e., baseline prostate-specific antigen (PSA), Gleason score and clinical...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781984/ https://www.ncbi.nlm.nih.gov/pubmed/35055380 http://dx.doi.org/10.3390/jpm12010065 |